A Multi-centre, Double-blind, Randomized, Parallel Group, Placebo Controlled Efficacy and Safety Study of Oral CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris
A multi-centre, double-blind, randomized, parallel group, placebo controlled efficacy and safety study of oral CTX-4430 for the treatment of moderate to severe facial acne vulgaris.
100 项与 Celtaxsys Aus Pty Limited 相关的临床结果
0 项与 Celtaxsys Aus Pty Limited 相关的专利(医药)
100 项与 Celtaxsys Aus Pty Limited 相关的药物交易
100 项与 Celtaxsys Aus Pty Limited 相关的转化医学